Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gut Microbiome Pill

NCT: NCT07243756 · COMPLETED

NCT IDNCT07243756
StatusCOMPLETED
Start Date2026-01-21
Completion2026-04-20

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of a 3D-printed ingestible pill designed to sample microbiota from the GI tract, focusing on the ability to collect data also from the small intestine. The study also aims to assess ease of use and transit time.

Frequently Asked Questions

What is Gut Microbiome Pill?

Gut Microbiome Pill is a clinical trial registered under NCT07243756. Current status: COMPLETED.

What is the status of NCT07243756?

The current status of NCT07243756 (Gut Microbiome Pill) is: COMPLETED.

When did Gut Microbiome Pill start?

Gut Microbiome Pill started on 2026-01-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.